Table 1 Demographic and clinical characteristics of the patients and control individuals in the training and validation sets
Characteristics | Control (n=100) | AMI (n=117) | AP (n=182) | P1 | P2 | P3 |
|---|---|---|---|---|---|---|
sex (F/M) | 19/81 | 20/97 | 49/133 | 7.17×10-1 | 1.97×10-1 | 7.77×10-2 |
age | 61.10±7.97 | 62.70±11.40 | 65.30±9.98 | 2.69×10-1 | 4.00×10-4 | 3.47×10-2 |
Hypertension | 53/100 | 69/117 | 127/182 | 3.40×10-1 | 4.91×10-3 | 6.81×10-2 |
Diabetes | 12/100 | 29/117 | 44/182 | 1.50×10-2 | 1.41×10-2 | 8.72×10-2 |
Glucose | 5.37±1.47 | 6.53±2.79 | 5.51±1.38 | 4.47×10-4 | 4.71×10-1 | 7.19×10-5 |
EF% | 64.38±5.45 | 59.19±8.38 | 63.75±6.67 | 1.03×10-5 | 4.90×10-1 | 3.41×10-6 |
HDL(mmol/L) | 1.17±0.30 | 1.06±0.28 | 1.12±0.62 | 1.84×10-2 | 5.12×10-1 | 4.80×10-2 |
LDL(mmol/L) | 2.95 ±0.79 | 2.81±0.86 | 2.61±0.77 | 2.77×10-1 | 8.20×10-4 | 3.57×10-2 |
CK-MB(U/L) | 15.26±20.91 | 80.84±121.17 | 13.06±12.60 | 2.10×10-4 | 3.72×10-1 | 6.80×10-11 |
cTnT(ng/ml) | 0.15±0.27 | 0.77±0.74 | 0.14±0.21 | 2.77×10-8 | 8.64×10-1 | 6.66×10-20 |